We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance

Results: 1-10 of 3,300

L’homme est ce qu’il mange de la sécurité alimentaire et protection de la biodiversité au brevet : les OGM dans un futur à découvrir
  • Maschietto Maggiore Besseghini Studio Legale
  • European Union, Italy
  • May 6 2015

La diversité biologique entendue comme variabilité des organismes vivants de toute origine (art. 2 de la Convention sur la diversité biologique

Global intellectual property newsletter - issue 0115
  • Clifford Chance LLP
  • China, European Union, Germany, Poland, Spain, United Kingdom, USA
  • January 21 2015

Establishment of the Unified European Patent Litigation System has been subject to many efforts of European leaders and legislators for more than four

New studies estimate health costs associated with endocrine-disrupting chemicals
  • Shook Hardy & Bacon LLP
  • European Union
  • March 6 2015

Three studies published in The Journal of Clinical Endocrinology & Metabolism have sought to quantify "the burden of disease and associated costs

Patent and pharma update January 2015
  • Herbert Smith Freehills LLP
  • European Union, United Kingdom
  • January 22 2015

This second edition of our regular patent and pharma update provides a round-up of significant cases and developments from United Kingdom and

DTU’s National Food Institute rejects EFSA’s assessment of bisphenol A
  • Shook Hardy & Bacon LLP
  • European Union
  • March 6 2015

The Technical University of Denmark's (DTU's) National Food Institute has rejected the European Food Safety Authority's (EFSA's) recent bisphenol A

European Commission Action Plan on Antimicrobial Resistance
  • Hogan Lovells
  • European Union
  • March 3 2015

On 26 February 2015, the European Commission published a progress report concerning the Commission's five year Action Plan on Antimicrobial

EU political update: 8 - 12 December 2014
  • Clifford Chance LLP
  • European Union
  • December 9 2014

As of 1 December 2014, the normal powers of the European Commission and the Court of Justice of the European Union apply to criminal matters in the

Getting a biosimilar drug approved in Europe updated guidance
  • Bereskin & Parr LLP
  • European Union
  • December 4 2014

The European Medicines Agency ("EMEA") has updated its 2005 guideline on principles for establishing biosimilarity between an innovator product and a

Advocate General's decision causes weighty problems for employers - obesity may be a disability
  • Bond Dickinson LLP
  • European Union
  • August 14 2014

In Kaltoft v Municipality of Billund C-35413, the Advocate General has given his opinion that obesity is not a protected characteristic under the EU

Stem cell patentability: European update following opinion of Advocate-General in ISCC and the Australian position
  • Herbert Smith Freehills LLP
  • Australia, European Union
  • August 14 2014

A recent Opinion of the Advocate-General of the Court of Justice of the European Union (CJEU) suggests that a clarification and moderation of the